PROLLENIUM MEDICAL TECHNOLOGIES INC.

Matched from indexed company URL: Prollenium Medical Technologies Inc.

FDA Registration(s)#

Registration, FEI, Name table
Registration	FEI	Name	Status	Initial importer	Expiration year	Address
3004423487	3004423487	PROLLENIUM MEDICAL TECHNOLOGIES INC.	1	N	2026-01-01	138 Industrial Pkwy N. Aurora Ontario CA L4G4C3
3019585045	3019585045	Prollenium Medical Technologies Inc.	1	N	2026-01-01	29 East Wilmot Street Richmond Hill Ontario CA L4B1A3

Registered Device Listings#

Registration key, Listing key, Premarket submission table
Registration key	Listing key	Premarket submission	Device	Product code	Decision date
210546	1617496551	P160042	REVANESSE ULTRA	LMH	2017-08-04
327146	1617496551	P160042	REVANESSE ULTRA	LMH	2017-08-04
210546	1276275511
327146	1276275511
210546	1423517162
327146	1423517162

Product Codes Associated With Registrations#

Product code, Registration listing records, Latest decision table
Product code	Registration listing records	Latest decision
LMH	2	2017-08-04

PMA#

Revanesse Versa+ with Lidocaine (1.0 mL and 1.2 mL) and Revanesse Lips+ with Lidocaine (1.0 mL and 1.2 mL)

2022-04-20

PROLLENIUM MEDICAL TECHNOLOGIES INC.138 Industrial Parkway Northaurora L4G 4 PMA NumberP160042 Supplement NumberS017 Date Received10/05/2021 Decision Date04/20/2022 Product Code LMH Advisory Committee General & Plastic Surgery Supplement Type135 Review Tra...